OPA1 is a dynamin-related GTPase that controls mitochondrial dynamics, cristae integrity, energetics and mtDNA maintenance. The exceptional complexity of this protein is determined by the presence, in humans, of eight different isoforms that, in turn, are proteolytically cleaved into combinations of membrane-anchored long forms and soluble short forms. Recent advances highlight how each OPA1 isoform is able to fulfill "essential" mitochondrial functions, whereas only some variants carry out "specialized" features. Long forms determine fusion, long or short forms alone build cristae, whereas long and short forms together tune mitochondrial morphology. These findings offer novel challenging therapeutic potential to gene therapy
Abstract: Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotyp...
Inner mitochondrial membrane fusion and cristae shape depend on optic atrophy protein 1, OPA1. Mutat...
Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotype characte...
OPA1 is a dynamin-related GTPase that controls mitochondrial dynamics, cristae integrity, energetics...
OPA1 is a GTPase that controls mitochondrial fusion, cristae integrity, and mtDNA maintenance. In hu...
OPA1 is a 120kDa large GTPase belonging to the dynamin superfamily. It is the only known mitochondri...
OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA), a blinding disease that affects...
OPA1, a dynamin-related guanosine triphosphatase mutated in dominant optic atrophy, is required for ...
AbstractThe studies addressing the molecular mechanisms governing mitochondrial fusion and fission h...
OPA1 mutations are the major cause of dominant optic atrophy (DOA) and the syndromic form DOA plus, ...
OPA1 is a GTPase that controls several functions, such as mitochondrial dynamics and energetics, mtD...
Many muscular and neurological disorders are associated with mitochondrial dysfunction and are often...
OPA1, a nuclear encoded mitochondrial protein causing autosomal dominant optic atrophy, is a key pla...
In the year 2000, the discovery of OPA1 mutations as causative for dominant optic atrophy (DOA) was ...
The OPA1 gene, encoding a dynamin-like mitochondrial GTPase, is involved in autosomal dominant optic...
Abstract: Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotyp...
Inner mitochondrial membrane fusion and cristae shape depend on optic atrophy protein 1, OPA1. Mutat...
Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotype characte...
OPA1 is a dynamin-related GTPase that controls mitochondrial dynamics, cristae integrity, energetics...
OPA1 is a GTPase that controls mitochondrial fusion, cristae integrity, and mtDNA maintenance. In hu...
OPA1 is a 120kDa large GTPase belonging to the dynamin superfamily. It is the only known mitochondri...
OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA), a blinding disease that affects...
OPA1, a dynamin-related guanosine triphosphatase mutated in dominant optic atrophy, is required for ...
AbstractThe studies addressing the molecular mechanisms governing mitochondrial fusion and fission h...
OPA1 mutations are the major cause of dominant optic atrophy (DOA) and the syndromic form DOA plus, ...
OPA1 is a GTPase that controls several functions, such as mitochondrial dynamics and energetics, mtD...
Many muscular and neurological disorders are associated with mitochondrial dysfunction and are often...
OPA1, a nuclear encoded mitochondrial protein causing autosomal dominant optic atrophy, is a key pla...
In the year 2000, the discovery of OPA1 mutations as causative for dominant optic atrophy (DOA) was ...
The OPA1 gene, encoding a dynamin-like mitochondrial GTPase, is involved in autosomal dominant optic...
Abstract: Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotyp...
Inner mitochondrial membrane fusion and cristae shape depend on optic atrophy protein 1, OPA1. Mutat...
Mutations in OPA1 cause autosomal dominant optic atrophy (DOA) as well as DOA+, a phenotype characte...